A STAT investigation into FDA's breakthrough device program; judge voids U.S. mask mandate for public transit

A STAT investigation has found that the FDA's breakthrough device program, meant to benefit patients, is delivering the biggest gains for companies.  ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

STAT+: FDA's breakthrough device program, meant to benefit patients, is delivering the biggest gains for companies By Katie Palmer and Mario Aguilar Molly Ferguson for STAT STAT spoke to dozens of experts, company executives, and officials to glean insight into the FDA's fast-growing breakthrough devices program. Read More Federal judge voids U.S. mask mandate for planes, other travel By Curt Anderson — Associated Press Ted S. Warren/AP The decision also said the CDC improperly failed to justify its decision and did not follow proper rulemaking. Read More STAT+: Nation's top cancer hospitals slap hefty markups on drugs, study says By Bob Herman BRENDAN SMIALOWSKI/AFP/GettyImages A new study finds health insurers paid drastically different prices for common cancer therapies at top cancer hospitals. Read More Sponsor content by STAT Color Code Podcast "Color Code" Podcast: STAT's podcast raising the alarm on racial inequities in American health care In this eight-episode podcast, award-winning journalist and host Nicholas St. Fleur weaves together stories and experiences of physicians, patients, historians, and other experts to illuminate the history of racism in the health care system and how it has — and continues to — impact people of color and underserved communities. Add "Color Code" to your STAT podcasts listening list and stream each episode on your preferred platform. Listen now. STAT+: Cel-Sci's CEO used private call to tip off select investors about cancer drug update By Adam Feuerstein Cel-Sci has not publicly discussed its intent to issue a data press release or to post new data on ClinicalTrials.gov this week. Read More STAT+: Breakthrough Device Tracker: An authoritative database of FDA's fast-tracked medical devices By Katie Palmer and Mario Aguilar and J. Emory Parker STAT identified hundreds of medical devices designated as "breakthroughs" by the FDA. Explore them by indication, manufacturer, and more. Read More Listen: Dismantling medical racism starts in the classroom By Nicholas St. Fleur Keisha Okafor for STAT For the third episode of "Color Code," we take a look at the groundswell of antiracism work in medicine and medical education. Read More Kizzmekia Corbett on the pandemic, public service, and her path to becoming a scientist By Helen Branswell Alex Hogan/STAT Kizzmekia Corbett, one of the Moderna Covid vaccine designers, takes on questions about her education, her inspirations, and the pandemic. Read More Opinion: Men and women may respond differently to vaccines. Research needs to account for that By Dawn Sinclair Shapiro Adobe Vaccine and drug developers need to evaluate sex differences as an integral part of their preclinical and clinical work. Read More Monday, April 18, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser